SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Unquoted Biotechs
An SI Board Since July 2001
Posts SubjectMarks Bans
253 23 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
153Antisoma says phase I cancer drug trials positive; phase II trials begin 2007 Ldr.praveen-10/2/2006
152Couple Quark stories: One with ALNY, another with PFE. ++++++++++++++ AlnylamIan@SI-9/26/2006
151MacuSight to Test Sirolimus in DME Using Two Delivery Methods: investorshub.comDewDiligence_on_SI-9/26/2006
150Astex Therapeutics Initiates Clinical Trial with Investigational Anti-Cancer Drunigel bates-9/26/2006
149About TransTech Pharma TransTech Pharma, Inc. is a majority-owned affiliate of Ian@SI-9/18/2006
148Avidex taken out - Message 22771690nigel bates-9/1/2006
147But will they ever get the chance to IPO ?nigel bates-8/31/2006
146J Exp Med. 2006 Aug 28; [Epub ahead of print] A novel chemokine receptor for Sscaram(o)uche-8/31/2006
145Some will remember that ChemoCentryx was a Tularik collaborator.scaram(o)uche-8/24/2006
144GlaxoSmithKline and ChemoCentryx Enter into Drug Discovery and Development Allianigel bates-8/24/2006
143Intralytix intralytix.com Intralytix, Inc. is a development stage biotechnologIan@SI-8/18/2006
142Inotek - PARP deal done with DNA. inotekcorp.com Inotek Pharmaceuticals CorporIan@SI-7/25/2006
141<i>recent small deals with Inflazyme and Boston Scientific as well</i&gscaram(o)uche-7/13/2006
140Transmolecular Corporation Venture Cap investors: transmolecular.com In clinicIan@SI-6/27/2006
139Metabolex Enters Into a Comprehensive Development and Commercialization Agreemennigel bates-6/26/2006
138Amyris Biotechnologies is focused on translating the promise of synthetic biolognigel bates-6/11/2006
137Roche Buys Test Drug For 'Good' Cholesterol By a WALL STREET JOURNAL StaIan@SI-5/9/2006
136FibroGen Licenses Oral HIF-PH Inhibitors, Including FG-2216 and FG-4592, to Astenigel bates-4/28/2006
135FivePrime and Boehringer Ingelheim Initiate Rheumatoid Arthritis Collaboration Tnigel bates-4/25/2006
134Hercules Provides $15.0 Million in Financing to Sirtris Pharmaceuticals, a Biophnigel bates-4/20/2006
133NOXXON Pharma AG Announces Global Strategic Alliance with Pfizer Thursday March nigel bates-3/23/2006
132Thanks Nigel for bringing it up. I will look into it. Also another one I recentdr.praveen-3/20/2006
131Fluidigm Signs Additional Strategic Agreements with In-Q-Tel for Continued Develnigel bates-3/20/2006
130Merck to Enter a Venture for Pain Drugs By ANDREW POLLACK Published: March 20, 2tnsaf-3/20/2006
129Structure of Human Cytochrome P450 2D6 Solved by GlaxoSmithKline with the Use ofnigel bates-3/17/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News